Introduction: Early recurrence of hepatocellular carcinoma (HCC) is a major risk factor affecting survival even after hepatectomy. Many clinical, biochemical parameters and pathological grading like fibrosis 1 index have been used for risk stratifying HCC. However not many studies have combined all of them. It is therefore important to risk stratify HCC especially with newer PE...

tumours of odontogenic origin have been reported in various domestic animals. ameloblastic fibroodontomais a rare tumour derived from odontogenic epithelium and pulpal mesenchyme. plain andformalised sections from masses on the front of the cranial aspect of the jaw and the end of the tongue of acastrated beef cattle from an abattoir was submitted to mt pleasant laboratories, launceston, austra...

A 63-year-old male has had medical records of hepatocellular carcinoma (HCC), segment 2 of liver (1.7 cm), and received lobectomy with assistance of radiofrequency tumour ablation 2 years as well as coronary artery disease and triple vessel disease, and he had performed percutaneous coronary intervention, including plain old balloon angioplasty and stent implantation in the past 5 years. Recent...

This paper presents a ten-year course of the disease in a patient with pancreatic neuroendocrine tumour NEN G1, and with confirmed single, asymptomatic metastasis to the left cardiac ventricle. Initially, the cardiac metastasis was visible only on a positron emission tomography (PET) scan using gallium-68-labelled somatostatin analogue; the sensitivity of an echocardiography scan was lower. Des...

Doxorubicin (DOX) is an anthracycline antibiotic with broad spectrum anti-tumour activity. Its effectiveness has been limited by the occurrence of dose-related myocardial and bone marrow toxicity. As oxidative stress is the main factor in DOX-induced cardiotoxicity, we presumed that agents which enhance endogenous antioxidants can prevent DOX induced cardiotoxicity. Animals received either DOX ...

From January 1954 to December 1985 cardiac myxoma was diagnosed in 75 patients at the Mayo Clinic. The clinical presentation was typical in 70 cases and was referred to as "sporadic myxoma". Forty four other cases of cardiac myxomas (five from the Mayo Clinic) presented with a combination of distinctive clinical features and these cases are described as "syndrome myxoma". The patients with synd...

Figure 1: (a and b) Magnetic resonance and computed tomography studies display the left ventricle mass, protruding into the pericardial space and infiltrating epicardial fat; 18 months after surgery, a new mass presented with similar characteristics and size. (c) Jelly tumour from the surgeon’s view. (d) Haematoxilin–eosin stain showing a myxoid pattern with a reticulated matrix and elongated c...

Historically it has been shown repeatedly that single high doses of radiation do not allow a therapeutic differential between tumor and critical normal tissues but dose fractionation does. The purpose of conventional dose fractionation is to increase dose to the tumor while preserving normal tissue function. Tumors are generally irradiated with 2Gy dose per fraction delivered daily to a more or...

Cardiac calcified amorphous tumour (CAT) is a rare non-neoplastic lesion with only a few cases reported in literature. We present an interesting case of CAT that was associated with unexpectedly low platelet count. A 40-year man presented with shortness of breath on exertion. Echocardiogram showed a mobile mass within the right atrium. Mass was surgically excised. His platelet count varied from...